NLRX1 is a regulator of mitochondrial antiviral immunity |
| |
Authors: | Moore Chris B Bergstralh Daniel T Duncan Joseph A Lei Yu Morrison Thomas E Zimmermann Albert G Accavitti-Loper Mary A Madden Victoria J Sun Lijun Ye Zhengmao Lich John D Heise Mark T Chen Zhijian Ting Jenny P-Y |
| |
Institution: | Department of Microbiology-Immunology, University of North Carolina, Chapel Hill, North Carolina 27599, USA. |
| |
Abstract: | The RIG-like helicase (RLH) family of intracellular receptors detect viral nucleic acid and signal through the mitochondrial antiviral signalling adaptor MAVS (also known as Cardif, VISA and IPS-1) during a viral infection. MAVS activation leads to the rapid production of antiviral cytokines, including type 1 interferons. Although MAVS is vital to antiviral immunity, its regulation from within the mitochondria remains unknown. Here we describe human NLRX1, a highly conserved nucleotide-binding domain (NBD)- and leucine-rich-repeat (LRR)-containing family member (known as NLR) that localizes to the mitochondrial outer membrane and interacts with MAVS. Expression of NLRX1 results in the potent inhibition of RLH- and MAVS-mediated interferon-beta promoter activity and in the disruption of virus-induced RLH-MAVS interactions. Depletion of NLRX1 with small interference RNA promotes virus-induced type I interferon production and decreases viral replication. This work identifies NLRX1 as a check against mitochondrial antiviral responses and represents an intersection of three ancient cellular processes: NLR signalling, intracellular virus detection and the use of mitochondria as a platform for anti-pathogen signalling. This represents a conceptual advance, in that NLRX1 is a modulator of pathogen-associated molecular pattern receptors rather than a receptor, and identifies a key therapeutic target for enhancing antiviral responses. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|